AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES In 2013, England’s National Ins...
Read moreAUTHORS: Amy Boyers, Solen Monteil, Mariam Bibi OBJECTIVES Early Access Programmes (EAPs) prov...
Read moreIntroduction What is the secret to a successful drug launch? One crucial factor is establishing a cr...
Read moreWe explore whether including the patient voice in early stages of drug development optimises patient...
Read moreOur latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreEffective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei...
Read moreScottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...
Read moreLooking to enhance your market access capabilities? Remap Consulting are the partner to help you lau...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreThis expert article focusses on the new proportionate approach, and the international recognition pr...
Read more